William R Wilson

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Long Non Coding Rna

Top Venues

Cancer gene therapy

International journal of radiation biology

Nature reviews. Clinical oncology

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Tet Woo Lee, Francis W Hunter, Peter Tsai, Cristin G Print, William R Wilson, Stephen M F Jamieson
Clonal dynamics limits detection of selection in tumour xenograft CRISPR/Cas9 screens. Cancer gene therapy (2023)
Way W Wong, Sophia F O'Brien-Gortner, Robert F Anderson, William R Wilson, Michael P Hay, Benjamin D Dickson
Hypoxia-activated prodrugs of phenolic olaparib analogues for tumour-selective chemosensitisation. RSC medicinal chemistry 14 (7) (2023)
Cho Rong Hong, Sunali Y Mehta, H D Sarath Liyanage, Sarah P McManaway, Ho H Lee, Jagdish K Jaiswal, Gib Bogle, Moana Tercel, Frederik B Pruijn, William R Wilson, Kevin O Hicks
Spatially-resolved pharmacokinetic/pharmacodynamic modelling of bystander effects of a nitrochloromethylbenzindoline hypoxia-activated prodrug. Cancer chemotherapy and pharmacology 88 (4) (2021)
Dean C Singleton, Alexandra M Mowday, Chris P Guise, Sophie P Syddall, Sally Y Bai, Dan Li, Amir Ashoorzadeh, Jeff B Smaill, William R Wilson, Adam V Patterson
Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefit. Cancer gene therapy (2021)
Dean C Singleton, Andrew Macann, William R Wilson
Therapeutic targeting of the hypoxic tumour microenvironment. Nature reviews. Clinical oncology 18 (12) (2021)
Tet Woo Lee, Way Wua Wong, Benjamin D Dickson, Barbara Lipert, Gary J Cheng, Francis W Hunter, Michael P Hay, William R Wilson
Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia. International journal of radiation biology 95 (12) (2019)